Overview
Matthew Sharp practices practicing medicine in Southampton, United Kingdom.
His clinical expertise encompasses Cerebral Amyloid Angiopathy and Primary Amyloidosis.
He is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Matthew M. Sharp
Is Matthew M. Sharp a top-rated expert for Cerebral Amyloid Angiopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Matthew M. Sharp is classified as an Experienced expert for Cerebral Amyloid Angiopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Matthew M. Sharp participate in research or clinical trials?
Yes. Matthew M. Sharp has published 12 articles and abstracts on conditions like Cerebral Amyloid Angiopathy. You can view a list of Matthew M. Sharp's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral Amyloid AngiopathyMr. Sharp isExperienced. Learn about Cerebral Amyloid Angiopathy.
- Primary AmyloidosisMr. Sharp isExperienced. Learn about Primary Amyloidosis.